8-KEarnings & Results

DEXCOM INC 8-K Report, Financial Results (Jan 15, 2009)

Filed January 15, 2009For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on January 15, 2009, to report preliminary, unaudited product revenue for the fourth quarter of 2008. The company anticipates approximately $2.4 million in product revenues for Q4 2008. This report also highlights a significant sequential increase in sensor revenues, up approximately 25% from Q3 2008, and indicates robust unit sales with approximately 1,200 starter kits sold during the quarter. These preliminary results were presented by CEO Terry Gregg at the J.P. Morgan 27th Annual Healthcare Conference. Investors should note that this information is furnished and not formally "filed" with the SEC, meaning it does not carry the same legal implications as a fully filed report. However, the reported figures provide a crucial update on the company's sales performance and operational momentum heading into 2009.

Key Highlights

  • 1DexCom reported estimated, unaudited product revenues of approximately $2.4 million for the fourth quarter of 2008.
  • 2The company sold approximately 1,200 starter kits in Q4 2008.
  • 3Sensor revenues saw a significant sequential increase of approximately 25% compared to the third quarter of 2008.
  • 4The information was presented by President and CEO Terry Gregg at the J.P. Morgan 27th Annual Healthcare Conference.
  • 5The presentation was webcast live and archived on DexCom's website.
  • 6This Form 8-K filing is furnished pursuant to Item 2.02 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.

Frequently Asked Questions

DexCom reported estimated, unaudited product revenues of approximately $2.4 million for the fourth quarter of 2008, with approximately 1,200 starter kits sold. Additionally, sensor revenues increased sequentially by about 25% compared to the third quarter of 2008.

This information was presented by DexCom's President and CEO, Terry Gregg, during remarks at the J.P. Morgan 27th Annual Healthcare Conference in San Francisco on January 15, 2009.

No, the information in this report is furnished pursuant to Item 2.02 of Form 8-K and is not deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it is provided for informational purposes but does not carry the same liability as a formally filed document.

Yes, the presentation was webcast live, and a link to the webcast was available on DexCom's website (www.dexcom.com) in the investor webcast section. The webcast was also archived for future reference.